ConductScience.org, home
CDK12: cyclin dependent kinase 12
API referenceFor AI assistants

Gene · 51755

Papers3,441

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 3,441

Download this page as JSON
TitleJournalYearPMIDFound bySource
Advances in Breast Cancer Research: Immunological, Pathological, and Pharmacological Perspectives for Improving Patient Outcomes.Int J Mol Sci202641752040PubTator, text miningPubMed
PD-L1 Expression in Prostate Cancer: Anatomopathological Features, Methodological Pitfalls, and Therapeutic Potential.Int J Mol Sci202641751934PubTator, text miningPubMed
Consensus Copy-Number Alteration Signatures from Clinical Panels Enable Pan-Cancer Risk Stratification and Therapy Response Association.Int J Mol Sci202641751900PubTator, text miningPubMed
Synergistic Antitumor Activity of Curcumin and the PARP1 Inhibitor PJ34 in Platinum-Sensitive and Resistant Ovarian Cancer Cells.Cancers (Basel)202641749873PubTator, text miningPubMed
Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res202641746190PubTator, text miningPubMed
Penile metastasis from prostate cancer with CDK12 mutation: A case report and literature review.Oncol Lett202641743014PubTator, text miningPubMed
Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer.J Natl Cancer Cent202641738039PubTator, text miningPubMed
Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance.J Natl Cancer Cent202641738032PubTator, text miningPubMed
CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability.J Pharm Anal202641732321PubTator, text miningPubMed
Breaking the boundaries of affinity selection-mass spectrometry: From ligand screening to target-ligand interaction insights.J Pharm Anal202641732319PubTator, text miningPubMed
Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India.Oncologist202641729953PubTator, text miningPubMed
The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications.Front Immunol202641727427PubTator, text miningPubMed
Comprehensive Genomic Profiling Across Diverse Solid Tumors: A Real-World Experience From India With FoundationOne®CDx Testing.Cureus202641717185PubTator, text miningPubMed
Loss of the tumor suppressor PTEN activates cell-intrinsic interferon signaling to drive immune resistance.Genes Dev202641708282PubTator, text miningPubMed
Roles of CDK12/CDK13 and development of inhibitors and degraders.Biomed Pharmacother202641687544PubTator, text miningPubMed
Phosphorylation-Dependent Regulation and Interactions of the Neutral Amino Acid Transporter SLC6A15: Implications for Major Depression and Neuropsychiatric Disorders.OMICS202641649124PubTator, text miningPubMed
[Homologous recombination repair gene variants in hormone-sensitive prostate cancer].Zhonghua Bing Li Xue Za Zhi202641644423PubTator, text miningPubMed
Precise control of transcription condensates across S phase balances linker histone expression with DNA replication, ensuring genome stability.Mol Cell202641643682PubTator, text miningPubMed
Breast Cancer Brain Metastases: Current Understanding and Future Directions.Curr Oncol Rep202641642399PubTator, text miningPubMed
Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine.J Clin Invest202641623173PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51755/papers?page=5

API referenceFor AI assistants